ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000253161.1	Ponatinib	Bladder urothelial carcinoma	0.007363712	Resistant
ENSG00000253161.1	Ponatinib	Lung squamous cell carcinoma	0.047155885	Sensitive